GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,267,000 | -0.1% | 29,104 | 0.0% | 0.37% | +16.2% |
Q1 2022 | $1,268,000 | -1.2% | 29,104 | 0.0% | 0.32% | -1.9% |
Q4 2021 | $1,283,000 | +15.4% | 29,104 | 0.0% | 0.32% | +6.3% |
Q3 2021 | $1,112,000 | -4.1% | 29,104 | 0.0% | 0.30% | -4.4% |
Q2 2021 | $1,159,000 | +15.0% | 29,104 | +3.0% | 0.32% | -2.2% |
Q1 2021 | $1,008,000 | -3.1% | 28,250 | 0.0% | 0.32% | -8.5% |
Q4 2020 | $1,040,000 | -2.2% | 28,250 | 0.0% | 0.35% | -13.1% |
Q3 2020 | $1,063,000 | -9.1% | 28,250 | -1.4% | 0.41% | -16.6% |
Q2 2020 | $1,169,000 | +7.6% | 28,650 | 0.0% | 0.49% | -6.7% |
Q1 2020 | $1,086,000 | -19.3% | 28,650 | 0.0% | 0.52% | +11.5% |
Q4 2019 | $1,346,000 | +10.1% | 28,650 | 0.0% | 0.47% | +5.9% |
Q3 2019 | $1,223,000 | +6.6% | 28,650 | 0.0% | 0.44% | +8.9% |
Q2 2019 | $1,147,000 | -4.2% | 28,650 | 0.0% | 0.41% | -7.9% |
Q1 2019 | $1,197,000 | +9.3% | 28,650 | 0.0% | 0.44% | +0.2% |
Q4 2018 | $1,095,000 | -9.4% | 28,650 | -4.7% | 0.44% | +5.5% |
Q3 2018 | $1,208,000 | +4.0% | 30,077 | +4.4% | 0.42% | -2.1% |
Q2 2018 | $1,162,000 | +3.2% | 28,815 | 0.0% | 0.43% | +1.2% |
Q1 2018 | $1,126,000 | -13.8% | 28,815 | -21.7% | 0.42% | -9.9% |
Q4 2017 | $1,306,000 | -12.6% | 36,815 | 0.0% | 0.47% | -16.0% |
Q3 2017 | $1,495,000 | -5.8% | 36,815 | 0.0% | 0.56% | -5.4% |
Q2 2017 | $1,587,000 | +2.3% | 36,815 | 0.0% | 0.59% | +2.4% |
Q1 2017 | $1,552,000 | +9.4% | 36,815 | 0.0% | 0.57% | +5.7% |
Q4 2016 | $1,418,000 | -10.7% | 36,815 | 0.0% | 0.54% | -15.2% |
Q3 2016 | $1,588,000 | -0.5% | 36,815 | 0.0% | 0.64% | -1.4% |
Q2 2016 | $1,596,000 | +6.9% | 36,815 | 0.0% | 0.65% | +4.7% |
Q1 2016 | $1,493,000 | +0.5% | 36,815 | 0.0% | 0.62% | +0.5% |
Q4 2015 | $1,485,000 | +4.9% | 36,815 | 0.0% | 0.62% | -0.2% |
Q3 2015 | $1,416,000 | -7.6% | 36,815 | 0.0% | 0.62% | -4.0% |
Q2 2015 | $1,533,000 | -9.8% | 36,815 | 0.0% | 0.64% | -10.6% |
Q1 2015 | $1,699,000 | +8.0% | 36,815 | 0.0% | 0.72% | +9.3% |
Q4 2014 | $1,573,000 | -7.0% | 36,815 | 0.0% | 0.66% | -13.3% |
Q3 2014 | $1,692,000 | -14.1% | 36,815 | 0.0% | 0.76% | -12.1% |
Q2 2014 | $1,969,000 | +0.1% | 36,815 | 0.0% | 0.86% | -3.7% |
Q1 2014 | $1,967,000 | +0.1% | 36,815 | 0.0% | 0.90% | -2.4% |
Q4 2013 | $1,966,000 | +3.6% | 36,815 | -2.6% | 0.92% | -0.3% |
Q3 2013 | $1,897,000 | +0.4% | 37,815 | 0.0% | 0.92% | +1.8% |
Q2 2013 | $1,890,000 | – | 37,815 | – | 0.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |